Archives

img-01

Japan Updates 2025 NHI Drug Prices

On December 20, 2024, the Japanese Fiscal Year 2025 NHI drug price revision was implemented. Price revisions in Japan are based on the “discrepancy rates” between the current NHI prices and the actual market prices obtained in the 2024 drug price survey. For... Read More

img-01

Japan Medical Device Reimbursement Update 2024

This article was originally posted on MedTech Intelligence. Medical Device reimbursement levels in Japan are now more in line with the reimbursement levels in the EU. The Japanese government has pledged not to allow Japanese device reimbursement to be as high as... Read More

img-01

Japan Drug Regulatory Updates

Japan has had a flurry of new drug regulations to ease their drug lag problem and make their country more conducive to innovative drugs. As mentioned last month, Japan’s PMDA is now allowing the submission of some innovative drug applications in English and will respond... Read More

img-01

Quick Asian Regulatory Updates

In late September, Singapore’s HSA outlined a new eCTD portal program for drugs that will start in early 2025. This is an eCTD portal version 1.0, better than the previous .9 version. This new program will be in a voluntary test phase... Read More

img-01

More Medical Devices Manufactured in Asia

Over the last 20 years, Western medical device makers have had a boom in device exports to Asia. During that time, most Asian countries’ populations have gotten wealthier, seen more government investment in healthcare, seen new, more and advanced healthcare insurance programs... Read More